Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Dual Five Alpha Reductase Inhibition Combined With Alpha Blockade in Men With Refractory Urinary Retention Secondary to BPH

NCT00680680 is registered in ClinicalTrials.gov with Franklin D. Gaylis, MD Inc. as lead sponsor.

NCT NCT00680680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00680680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Dual Five Alpha Reductase Inhibition Combined With Alpha Blockade in Men With Refractory Urinary Retention Secondary to BPH
Lead sponsor
Franklin D. Gaylis, MD Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2004
Completion date
February 29, 2008
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, urinary retention